Overview
| Generic Names: | Cyclobenzaprine HCL |
|---|---|
| Trade Names: | Cyclobenz; Flexeril; Flexiban; Proeptatriene; Proheptatriene |
| PharmGKB Accession Id: | PA449160 |
Description
Cyclobenzaprine is a skeletal muscle relaxant and a central nervous system (CNS) depressant. Cyclobenzaprine acts on the locus coeruleus where it results in increased norepinephrine release, potentially through the gamma fibers which innervate and inhibit the alpha motor neurons in the ventral horn of the spinal cord. It is structurally similar to Amitriptyline, differing by only one double bond. (source: Drug Bank)
Indication
For use as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. (source: Drug Bank)
ATC Therapeutic Category
- M03BX:Other centrally acting agents
Pharmacology, Interactions, and Contraindications
Mechanism Of Action
Like other tricyclic antidepressants, cyclobenzaprine exhibits anticholinergic activity, potentiation of norepinephrine, and antagonism of reserpine. Cyclobenzaprine does not directly act on the neuromuscular junction or the muscle but relieves muscle spasms through a central action, possibly at the brain stem level. Cyclobenzaprine binds to the serotonin receptor and is considered a 5-HT2 receptor antagonist that reduces muscle tone by decreasing the activity of descending serotonergic neurons. (source: Drug Bank)
Pharmacology
Cyclobenzaprine, closely related to the antidepressant amitriptyline, is used as a skeletal muscle relaxant to reduce pain and tenderness and improve mobility. Unlike dantrolene, cyclobenzaprine cannot be used to treat muscle spasm secondary to cerebral or spinal cord disease. (source: Drug Bank)
Food Interactions
Avoid alcohol.
Take with food to reduce irritation.
(source:
Drug Bank)
Absorption, Distribution, Metabolism, Elimination & Toxicity
Biotransformation
Extensively metabolized (gastrointestinal and hepatic). (source: Drug Bank)
Protein Binding
Very high (93%) (source: Drug Bank)
Absorption
Slowly but well absorbed after oral administration (source: Drug Bank)
Toxicity
Oral mouse and rat LD<sub>50</sub> are 338 mg/kg and 425 mg/kg respectively. Signs of overdose include agitation, coma, confusion, congestive heart failure, convulsions, dilated pupils, disturbed concentration, drowsiness, hallucinations, high or low temperature, increased heartbeats, irregular heart rhythms, muscle stiffness, overactive reflexes, severe low blood pressure, stupor, and vomiting. (source: Drug Bank)
Isomeric SMILES Code:
CN(C)CCC=C1c2ccccc2C=Cc3c1cccc3 (source: Drug Bank)
The following genes are in curated knowledge about this drug.
| Gene | Relationship | Evidence | |
|---|---|---|---|
|
|
CYP1A2 |
|
Publications |
|
|
CYP2D6 |
|
Publications |
|
|
CYP3A |
|
Publications |
|
|
CYP3A4 |
|
Publications |
|
|
CYP3A5 |
|
Publications |
A list of non-curated publications that mention this drug along with other genes is available.
Drug Targets
| Gene | Description | |
|---|---|---|
| HTR2A |
|
(source: Drug Bank) |
A list of non-curated publications that mention this drug along with other drugs is available.
Drug Interactions
| Drug | Description | |
|---|---|---|
| donepezil |
|
Possible antagonism of action (source: Drug Bank) |
| galantamine |
|
Possible antagonism of action (source: Drug Bank) |
| rivastigmine |
|
Possible antagonism of action (source: Drug Bank) |
Non-Curated Information
A list of non-curated publications that mention this drug along with other diseases is available.
Additional Datasets
These datasets are minimally curated and are sorted alphabetically by title.
LinkOuts
Common Searches
Search PubMed
Search Medline Plus
Search PubChem
Search CTD
Non-Curated Publications
A list of non-curated publications that mention this drug is available.
